Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
Boston Children's Hospital · Dana-Farber Cancer Institute · +38 more institutions
Abstract
The Primary Immune Deficiency Treatment Consortium was formed to analyze the results of hematopoietic-cell transplantation in children with severe combined immunodeficiency (SCID) and other primary immunodeficiencies. Factors associated with a good transplantation outcome need to be identified in order to design safer and more effective curative therapy, particularly for children with SCID diagnosed at birth.
We collected data retrospectively from 240 infants with SCID who had received transplants at 25 centers during a 10-year period (2000 through 2009).
Citation impact
- FWCI
- 27.29
- Percentile
- 100%
- References
- 38
Authors
39- SPSung‐Yun PaiCorresponding
Boston Children's Hospital, Dana-Farber Cancer Institute
- BRBrent R. Logan
Memorial Sloan Kettering Cancer Center, Medical College of Wisconsin, National Institute of Allergy and Infectious Diseases, National Institutes of Health
- LMLinda M. Griffith
Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Institute of Allergy and Infectious Diseases
- RHRebecca H. Buckley
Memorial Sloan Kettering Cancer Center, Duke Medical Center
- RPRoberta Parrott
Memorial Sloan Kettering Cancer Center, Duke Medical Center
Topics & keywords
- Medicine
- Severe combined immunodeficiency
- Transplantation
- Sibling
- Immunodeficiency
- Hematopoietic stem cell transplantation
- Immunology
- Pediatrics
- Good health and well-being